Source: IHU Méditerranée-Infection

video

Dr. Harvey Risch, MD, PhD, Professor of Epidemiology Yale University, presents an informative session on hydroxychloroquine, to the Mediterranee Infection, France.

Dr. Risch gives a succinct history of the politics of hydroxychloroquine in the USA, which has had global effect, as many countries look to the USA for guidance.

Corruption and manipulation from behind the scenes around the world are brought to the surface for scrutiny.

Friendly ‘companion’ agents such as azithromycin, doxycycline, zinc, vitamin D, budesonide, colchicine, fluvoxamine, bromhexine, aspirin potentiate HCQ’s benefits a lot. The statistical analysis of ivermectin is also covered.





Related

This doctor cured 5000 corona patients with hydroxychloroquine

The Chloroquine Wars Part V – A Closer Look at RCTs Studying Hydroxychloroquine Efficacy

UK-based Meta Analysis Peer Reviewed & Published Suggests Ivermectin A Key Public Health Weapon in the War Against COVID-19

Hydroxychloroquine is the smartest drug in history

How hydroxychloroquine works at the cellular level

India Treats Medical Staff Prophylactically and Early, and It Makes a Difference – The Chloroquine Wars Part XXXI

Censorship Kills: The Shunning of a COVID Therapeutic

Is the vaccine safe? Undoing the spin on the vaccine. We have safe and effective treatment options for COVID.

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI

The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.

Read More »

Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients

We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.

Read More »